Speech Path Pod
Speech Path Pod Ep. 20: Connected speech in MCI & AD w/ Dr. Kimberly Mueller
Welcome back to another episode of the Speech Path Pod!
In this episode, I sat down to talk with Dr. Mueller about:
-Preclinical detection of speech changes in those w/o subjective memory complaints
-Course of speech changes for those with MCI to AD
-Use of connected speech as an AD biomarker
-Much more!
Dr. Mueller’s research focuses on understanding the neural mechanisms and behavioral aspects of speech and language changes across the spectrum of aging, preclinical Alzheimer’s disease, Mild Cognitive Impairment (MCI), Alzheimer’s disease (AD) dementia, and other forms of dementia. Her work utilizes naturalistic speech-language samples as one means of analyzing and understanding subtle changes to communication. Dr. Mueller is also interested in the design and testing of identification methods of early cognitive change in the presence of AD biomarkers, and multimodal therapeutic interventions to address cognitive-communication difficulties in MCI and dementia due to neurodegenerative disease.
Check out her lab's website at: https://ccandl.csd.wisc.edu/
Welcome back to another episode of the Speech Path Pod!
In this episode, I sat down to talk with Dr. Mueller about:
-Preclinical detection of speech changes in those w/o subjective memory complaints
-Course of speech changes for those with MCI to AD
-Use of connected speech as an AD biomarker
-Much more!
Dr. Mueller’s research focuses on understanding the neural mechanisms and behavioral aspects of speech and language changes across the spectrum of aging, preclinical Alzheimer’s disease, Mild Cognitive Impairment (MCI), Alzheimer’s disease (AD) dementia, and other forms of dementia. Her work utilizes naturalistic speech-language samples as one means of analyzing and understanding subtle changes to communication. Dr. Mueller is also interested in the design and testing of identification methods of early cognitive change in the presence of AD biomarkers, and multimodal therapeutic interventions to address cognitive-communication difficulties in MCI and dementia due to neurodegenerative disease.
Check out her lab's website at: https://ccandl.csd.wisc.edu/